| Tag | Content |
|---|
EnhancerAtlas ID | HS109-18533 |
Organism | Homo sapiens |
Tissue/cell | Kasumi-1 |
Coordinate | chr5:88029820-88030430 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ESRRB | MA0141.3 | chr5:88030015-88030026 | TCAAGGTCAAT | + | 6.02 | | NEUROG1 | MA0623.2 | chr5:88030074-88030084 | GACATATGTC | + | 6.02 | | NEUROG1 | MA0623.2 | chr5:88030074-88030084 | GACATATGTC | - | 6.02 | | NFAT5 | MA0606.1 | chr5:88030130-88030140 | AATGGAAAAT | - | 6.02 | | NFATC1 | MA0624.1 | chr5:88030130-88030140 | AATGGAAAAT | - | 6.02 | | NFATC3 | MA0625.1 | chr5:88030130-88030140 | AATGGAAAAT | - | 6.02 | | RORA | MA0071.1 | chr5:88030014-88030024 | ATCAAGGTCA | + | 6.02 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_10860 | chr5:88018226-88045791 | CD20 | | SE_58943 | chr5:88025259-88059632 | Ly3 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH05I088730 | chr5 | 88025849 | 88034726 |
|
Enhancer Sequence | ATGCATTTAC TTCCTCTCAC TAGAAGAAAA AAACAAACAA AAGAGAGTAT GTTCACTTAA 60
AAAAAAAAAG CTTGACAAAA TGGAGTGCTT AGAGGAGTTT TATATTTAAT ATGTCATCCT 120
GAATCATTAT TGTGAATATG TTATGAACTT AGTTTGAATT AATAGATTCT ACGGGATAAA 180
AAGAGAATAA GAACATCAAG GTCAATTCTG CTCTATACTT TGCTGTCAGC TGAAGGTCAG 240
ATGGACACAC TGAAGACATA TGTCACTTAT CTATTAAGCC TGTGTGAGAT CTGGTTTATA 300
TAAACAATCA AATGGAAAAT TAGCTGGGTA ATTTCAAAAG AAGGGGGAGA AAAAAGTCTG 360
TTAAGCAGTG CAATGAAGCT TGAATAGATC AGAAGAAACT AAAACCCCAG CTCGGTAGAT 420
GCCGATACTG GTTTGCATGG AGGAGTTATT TTGCTAAAAG GAAGTAAAAC CGCTTCGTGA 480
AATGTGTTGT CCTGTGATAT GACAAGCACT GGGCCAGTGT GCGAAAATGG AAATGCTTCA 540
CGGAGGCCTT GAGAAAAGTT TGTTTTTTTT TTTTTTTTTT TTTTTTTTTT TTTTTAGCAT 600
TTTCTACAGT 610
|
